Lancet: Natural immunity is effective against COVID-19

This article discussed the study published by Lancet two days ago that showed that previous SARS-CoV-2 infection protects against re-infection. It is a large study considering it included 65 studies from 19 countries. The result showed that previous infection is highly protective against the Wuhan type, which they called ancestral, and the alpha, beta, and…

Breakthrough infection provides greater protection than a booster shot

This article talks about a new preprint study from Oxford University showing that a COVID-19 breakthrough infection provides better and longer protection than a booster shot. A breakthrough infection is a COVID-19 infection in those with COVID-19 jabs. In the investigation, the authors compared whether a third or booster shot or a breakthrough infection following…

Natural immunity vs. Pfizer BNT162b2 vs. Coronavac

The study, Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong Kong, was published in the peer-reviewed journal Respirology. The two injections are different. The Pfizer BNT162b2  uses the modified RNA technology enclosed in a lipid nanoparticle. In contrast, the Coronavac uses an old vaccine technology using inactivated viruses that cannot replicate…

Naturally acquired antibodies from COVID-19 last up to 20 months

The Journal of the American Medical Association recently published a study from the Department of Surgery, Johns Hopkins University School of Medicine, on February 3, 2022. The research answered the question. How long do naturally acquired antibodies against the SARS-CoV-2 virus last? Specifically, they focused on antibodies against the receptor-binding domain (RBD) of the SARs-CoV-2,…

CDC data shows the equal risk of COVID-19 hospitalization for convalescent and vax induced immunity

The CDC has a Morbidity and Mortality Weekly Report (MMWR) report released on January 19, 2021. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis — California and New York, May–November 2021. The table below shows the number of COVID-19 cases and hospitalizations among the Vaccinated and Unvaccinated in California. The table…

The human body is a SARS-CoV-2 variant factory, and that’s a good thing

The media and health agencies have conditioned the population that variants are dangerous. The discovery of the Delta and omicron variant has led governments to push for more vaccinations, whether first, second dose, booster, or further boosters. They also use it as an excuse to vaccinate children who don’t need it. The paper, Intra-host variation and…

Ten Studies showing a low risk of COVID-19 reinfection among unvaccinated

A FaceBook friend asked me what is the chance of reinfection if you recovered from COVID-19. A quick search revealed many studies that show a low risk of infection. I answered her and made this article. The studies are listed in no particular order. Emphasis added. 1. Re-infection Rates among Patients who Previously Tested Positive…

Discoverer of the omicron variant successfully treated a six-year-old COVID patient with the “worst symptoms”

Dr. Angelique Coetzee of South Africa is credited with discovering the omicron variant among her patients. ABC Radio National interviewed Dr. Coetzee about the omicron cases that she has seen. She said most have mild symptoms like fever, fatigue, headaches, body aches, and nausea. No one showed symptoms commonly seen with the Delta variant: “No…